Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TOCILIZUMAB Cause Glomerular filtration rate decreased? 29 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 29 reports of Glomerular filtration rate decreased have been filed in association with TOCILIZUMAB (Tocilizumab-anoh). This represents 0.0% of all adverse event reports for TOCILIZUMAB.

29
Reports of Glomerular filtration rate decreased with TOCILIZUMAB
0.0%
of all TOCILIZUMAB reports
4
Deaths
3
Hospitalizations

How Dangerous Is Glomerular filtration rate decreased From TOCILIZUMAB?

Of the 29 reports, 4 (13.8%) resulted in death, 3 (10.3%) required hospitalization.

Is Glomerular filtration rate decreased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TOCILIZUMAB. However, 29 reports have been filed with the FAERS database.

What Other Side Effects Does TOCILIZUMAB Cause?

Drug ineffective (32,342) Rheumatoid arthritis (20,652) Pain (18,384) Off label use (18,256) Arthralgia (15,536) Joint swelling (14,831) Fatigue (13,802) Rash (12,327) Drug intolerance (11,952) Contraindicated product administered (11,547)

What Other Drugs Cause Glomerular filtration rate decreased?

SACUBITRIL\VALSARTAN (531) EMTRICITABINE\TENOFOVIR DISOPROXIL (275) INOTERSEN (264) FINERENONE (250) METFORMIN (248) TOLVAPTAN (244) VOCLOSPORIN (223) CANAGLIFLOZIN (222) FUROSEMIDE (200) DAPAGLIFLOZIN PROPANEDIOL (195)

Which TOCILIZUMAB Alternatives Have Lower Glomerular filtration rate decreased Risk?

TOCILIZUMAB vs TOCILIZUMAB-AAZG TOCILIZUMAB vs TOCOPHEROL TOCILIZUMAB vs TOFACITINIB TOCILIZUMAB vs TOFERSEN TOCILIZUMAB vs TOLNAFTATE

Related Pages

TOCILIZUMAB Full Profile All Glomerular filtration rate decreased Reports All Drugs Causing Glomerular filtration rate decreased TOCILIZUMAB Demographics